Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab.

Oncotarget · 2016 · PMC4808050 · PMID 26460956

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

of borderline significanceP = 0.088so close (0.05 < p ≤ 0.1)

In the concurrent-trastuzumab cohort, IMC RT was of borderline significance ( P = 0.088) in increasing the rate of LVEF dysfunction.

also in 1,681 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.